Page last updated: 2024-08-23

4-methoxyamphetamine and losartan potassium

4-methoxyamphetamine has been researched along with losartan potassium in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (25.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fandrey, J; Gassmann, M; Gembruch, U; Hasegawa, J; Jelkmann, W; Katschinski, DM; Meller, B; Schramm, U; Schumacher, D; Wagner, KF	1
Aydin, Z; de Fijter, JW; Mallat, MJ; Rabelink, TJ; Schaapherder, AF; van Kooten, C; van Zonneveld, AJ	1
Dhital, KK; Doyle, A; Feneley, MP; Gao, L; Graham, RM; Harvey, RP; Hicks, M; Iyer, A; Jabbour, A; Jansz, PC; Jayewardene, D; Kumarasinghe, G; Macdonald, PS; Rao, P; Wan, B	1

Trials

1 trial(s) available for 4-methoxyamphetamine and losartan potassium

Article	Year
Randomized trial of short-course high-dose erythropoietin in donation after cardiac death kidney transplant recipients. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2012, Volume: 12, Issue:7 Topics: Adult; Death; Dose-Response Relationship, Drug; Double-Blind Method; Erythropoietin; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Placebos; Tissue Donors	2012

Article

Year

Randomized trial of short-course high-dose erythropoietin in donation after cardiac death kidney transplant recipients.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2012, Volume: 12, Issue:7

Topics: Adult; Death; Dose-Response Relationship, Drug; Double-Blind Method; Erythropoietin; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Placebos; Tissue Donors

2012

Other Studies

3 other study(ies) available for 4-methoxyamphetamine and losartan potassium

Article	Year
Chronic inborn erythrocytosis leads to cardiac dysfunction and premature death in mice overexpressing erythropoietin. Blood, 2001, Jan-15, Volume: 97, Issue:2 Topics: Age Factors; Animals; Blood Vessels; Cardiovascular Diseases; Chronic Disease; Death; Electrocardiography; Erythropoietin; Exercise Tolerance; Female; Hematocrit; Hemodynamics; Humans; Male; Mice; Mice, Transgenic; Microscopy, Electron; Models, Animal; Organ Size; Polycythemia; Sex Factors; Survival Rate	2001
Should deaths of neonates in trial have been more openly reported? Bulletin of medical ethics, 1993, Volume: No. 93 Topics: Anemia; Conflict of Interest; Death; Deception; Disclosure; DNA, Recombinant; Drug Industry; Drug-Related Side Effects and Adverse Reactions; Editorial Policies; Erythropoietin; Ethics Committees; Ethics Committees, Research; Financial Support; Hormones; Human Experimentation; Humans; Infant, Newborn; Infant, Premature; Information Dissemination; Information Services; Mortality; Peer Review; Placebos; Professional Misconduct; Publishing; Research Design; Research Personnel; Risk; Risk Assessment; United Kingdom	1993
Increasing the tolerance of DCD hearts to warm ischemia by pharmacological postconditioning. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2014, Volume: 14, Issue:8 Topics: Animals; Death; Disease Models, Animal; Edema; Erythropoietin; Guanidines; Heart; Heart Failure; Heart Transplantation; Ischemic Preconditioning; Lactates; Myocardium; Nitroglycerin; Oxygen Consumption; Perfusion; Pyrazoles; Swine; Time Factors; Transplantation, Homologous; Troponin; Warm Ischemia	2014